Xbrane Biopharma AB Cash Flow-to-Debt Ratio
Xbrane Biopharma AB cash flow-to-debt ratio. Xbrane Biopharma AB (XBRANE) has a Cash Flow-to-Debt Ratio of -0.05x as of June 2026, meaning its operating cash flow of Skr-4.82 Million could theoretically repay 0% of its total liabilities (Skr103.76 Million) in one year. Check XBRANE cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Xbrane Biopharma AB (2013–2025)
Cash flow-to-debt ratio of Xbrane Biopharma AB from 2013 to 2025. Historical debt coverage capacity for Xbrane Biopharma AB across 13 annual periods. Check cash flow reinvestment rate of Xbrane Biopharma AB to assess the company's total reinvestment commitment from operating cash flow.
Xbrane Biopharma AB Cash Flow-to-Debt Ratio by Year (2013–2025)
Xbrane Biopharma AB cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Xbrane Biopharma AB. For the full cash flow conversion analysis, see XBRANE cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.26x | Skr-250.69 Million | Skr110.97 Million | ▼ -970.8% |
| 2024 | -0.21x | Skr-133.73 Million | Skr633.89 Million | ▲ +75.0% |
| 2023 | -0.84x | Skr-406.68 Million | Skr482.17 Million | ▼ -15.5% |
| 2022 | -0.73x | Skr-193.92 Million | Skr265.63 Million | ▲ +14.7% |
| 2021 | -0.86x | Skr-219.61 Million | Skr256.69 Million | ▲ +26.1% |
| 2020 | -1.16x | Skr-238.41 Million | Skr206.06 Million | ▼ -20.4% |
| 2019 | -0.96x | Skr-148.59 Million | Skr154.62 Million | ▼ -449.4% |
| 2018 | 0.28x | Skr46.71 Million | Skr169.81 Million | ▲ +116.8% |
| 2017 | -1.63x | Skr-36.85 Million | Skr22.55 Million | ▲ +55.2% |
| 2016 | -3.65x | Skr-39.43 Million | Skr10.81 Million | ▼ -719.3% |
| 2015 | -0.45x | Skr-12.39 Million | Skr27.82 Million | ▲ +93.5% |
| 2014 | -6.83x | Skr-2.67 Million | Skr390.70K | ▼ -57.1% |
| 2013 | -4.35x | Skr-2.20 Million | Skr505.44K | — |